AGT and COVID-19: Coronavirus mediated ACE2 receptor down-regulation may escalate the counter-part impact of the renin-angiotensin I-angiotensin II-AT1R axis and contribute to the deleterious hyper-inflammatory response of COVID-19 in the lungs (21, 22).